Active Efflux System for Cisplatin in Cisplatin-resistant Human KB Cells-Reference-Cited by-同舟云学术

Active Efflux System for Cisplatin in Cisplatin-resistant Human KB Cells

Published:1994-04 Issue:4 Volume:85 Page:426-433
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Fujii Ryu-ichi,Mutoh Masato,Niwa Kiyoshi,Yamada Kazutaka,Aikou Takashi,Nakagawa Masayuki,Kuwano Michihiko,Akiyama Shin-ichi

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.1994.tb02376.x/fullpdf

Reference31 articles.

1. Cisplatin;Loehrer;Ann. Intern. Med.,1984

2. Mechanisms of resistance to cisplatin and alkylating agents

3. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster;Saburi;Cancer Res.,1989

4. Levels of glutathione S transferase π mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin;Nakagawa;Jpn. J. Cancer Res.,1988

5. Differential uptake of cis-diamminedichloroplatinum(II) by sensitive and resistant murine LI210 leukemia cells;Ward;Cancer Res.,1987

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells;Molecules;2024-01-04

2. The Role of Chloride Channels in the Multidrug Resistance;Membranes;2021-12-28

3. Cell Death Induction and Protection by Activation of Ubiquitously Expressed Anion/Cation Channels. Part 1: Roles of VSOR/VRAC in Cell Volume Regulation, Release of Double-Edged Signals and Apoptotic/Necrotic Cell Death;Frontiers in Cell and Developmental Biology;2021-01-12

4. Overexpression of ABCC2 and NF-Κβ/p65 with Reduction in Cisplatin and 4OH-Tamoxifen Sensitivity in MCF-7 Breast Cancer Cells: The Influence of TNF-α;Pharmaceutical Sciences;2020-06-27

5. Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells;Frontiers in Oncology;2020-06-26